Evidence map›Paper›PMID 36122374›Full record

ArticleBlood2023

Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens.

Vanja Karamatic Crew, Louise A Tilley, Timothy J Satchwell, Samah A AlSubhi, Benjamin Jones, Frances A Spring, Piers J Walser, Catarina Martins Freire, Nicoletta Murciano, Maria Giustina Rotordam and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Open biology · 2025
    Review
  5. Article
  6. Role of channels in the ObioRxiv : the preprint server for biology · 2025
    Article
  7. Blood group antigens and malaria susceptibility.Frontiers in cellular and infection microbiology · 2025
    Review
  8. Review
  9. Review
  10. A Hierarchical Mechanotransduction System: From Macro to Micro.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Long-Read Sequencing in Blood Group Genetics.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  18. Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  19. A new blood group system: scientific relevance and media resonance.Blood transfusion = Trasfusione del sangue · 2022
    Article
  20. A Review of the Knops Blood Group System.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 3 countries.

Vanja Karamatic CrewInternational Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, United Kingdom.ORCID 0000-0003-1412-9107
Louise A TilleyInternational Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, United Kingdom.ORCID 0000-0001-8244-4331
Timothy J SatchwellSchool of Biochemistry, University of Bristol, Bristol, United Kingdom.ORCID 0000-0003-0590-292X
Samah A AlSubhiInternational Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, United Kingdom.
Benjamin JonesInternational Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, United Kingdom.
Frances A SpringNational Institute for Health Research Blood and Transplant Research Unit in Red Blood Cell Products, University of Bristol, Bristol, United Kingdom.
Piers J WalserClinical Biotechnology Centre, NHS Blood and Transplant, Bristol, United Kingdom.
Catarina Martins FreireSchool of Biochemistry, University of Bristol, Bristol, United Kingdom.
Nicoletta MurcianoTheoretical Medicine and Biosciences, Saarland University, Homburg, Germany.ORCID 0000-0002-8046-7297
Maria Giustina RotordamResearch and Development, Nanion Technologies, Munich, Germany.
Svenja J WoestmannDeutsches Rotes Kreuz, Institute Bad Kreuznach, Bad Kreuznach, Germany.
Marwa HamedKuwait Central Blood Bank, Hawally, Kuwait.
Reem AlradwanKuwait Central Blood Bank, Hawally, Kuwait.
Mouza AlKhrouseyKuwait Central Blood Bank, Hawally, Kuwait.
Ian SkidmoreRed Cell Immunohaematology, NHS Blood and Transplant, Birmingham, United Kingdom.
Sarah LewisRed Cell Immunohaematology, NHS Blood and Transplant, Birmingham, United Kingdom.
Shimon HussainRed Cell Immunohaematology, NHS Blood and Transplant, Birmingham, United Kingdom.
Jane JacksonHaematology Department at Birmingham Women's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.
Tom LathamNHS Blood and Transplant, Bristol, United Kingdom.
Mark D KilbyCollege of Medical & Dental Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-9987-4223
William LesterHaematology Department at Birmingham Women's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom.
Nadine BeckerResearch and Development, Nanion Technologies, Munich, Germany.
Markus RapediusResearch and Development, Nanion Technologies, Munich, Germany.ORCID 0000-0002-9917-9922
Ashley M ToyeSchool of Biochemistry, University of Bristol, Bristol, United Kingdom.ORCID 0000-0003-4395-9396
Nicole M ThorntonInternational Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, United Kingdom.ORCID 0000-0002-8635-0997
NHS Blood and Transplant · GBNanion (Germany) · DEBirmingham Women's Hospital · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBGerman Red Cross · DEUniversity of Bristol · GB

Funding

Medical Research Council MR/V010506/1
6 · The paper itself

Abstract

Despite the identification of the high-incidence red cell antigen Era nearly 40 years ago, the molecular background of this antigen, together with the other 2 members of the Er blood group collection, has yet to be elucidated. Whole exome and Sanger sequencing of individuals with serologically defined Er alloantibodies identified several missense mutations within the PIEZO1 gene, encoding amino acid substitutions within the extracellular domain of the Piezo1 mechanosensor ion channel. Confirmation of Piezo1 as the carrier molecule for the Er blood group antigens was demonstrated using immunoprecipitation, CRISPR/Cas9-mediated gene knockout, and expression studies in an erythroblast cell line. We report the molecular bases of 5 Er blood group antigens: the recognized Era, Erb, and Er3 antigens and 2 novel high-incidence Er antigens, described here as Er4 and Er5, establishing a new blood group system. Anti-Er4 and anti-Er5 are implicated in severe hemolytic disease of the fetus and newborn. Demonstration of Piezo1, present at just a few hundred copies on the surface of the red blood cell, as the site of a new blood group system highlights the potential antigenicity of even low-abundance membrane proteins and contributes to our understanding of the in vivo characteristics of this important and widely studied protein in transfusion biology and beyond.

Indexed as

Anemia, Hemolytic, CongenitalBlood Group AntigensErythrocytesHumansInfant, NewbornIon ChannelsMechanotransduction, CellularMutation, MissenseBlood Group AntigensIon ChannelsPIEZO1 protein, human

Identifiers

PMID36122374
PMCPMC10644042
OpenAlexW4296301849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.